Invisalign maker Align Technology to invest Rs 1,800 crore in Hyderabad plant

US firm Align Technology will invest Rs 1,800 crore in Hyderabad for its first Indian manufacturing plant. This facility will be the company's fourth globally. It is expected to create over 300 jobs. The investment will boost Align Technology's existing operations in the city. The new plant will support its worldwide production of clear aligners.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BphLCdz
via IFTTT

Read More

Pregabalin moved to Schedule H1 as centre cracks down on drug misuse

Pregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims to curb its misuse, especially among youth. Previously available over-the-counter, it now requires strict prescriptions. Pharmacies must maintain records and display prominent warnings.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Si5YHum
via IFTTT

Read More

ICMR replaces old system with single window approval for medical studies

The Indian Council of Medical Research has introduced a unified ethics approval process for multicentre medical studies, replacing the previous fragmented, site-by-site system. This significant reform aims to expedite research timelines, reduce costs, and expand participation to rural and vulnerable populations, fostering more representative and robust health policy evidence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KnMQj3G
via IFTTT

Read More

Eli Lilly’s obesity drug shows up to 30% weight loss in trial

Eli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This once-weekly injection targets multiple hormone receptors. The drug also improved heart health markers. Experts believe retatrutide could be a game-changer for treating obesity and improving patient health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FJEq4Sa
via IFTTT

Read More

No cosmetic job with jabs, warns drug regulator CDSCO

The notice issued by the Central Drugs Standard Control Organisation (CDSCO) cites provisions of the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QKycW0G
via IFTTT

Read More

India plans national registry to track implantable medical devices and patients

India is set to launch a national registry for implantable medical devices. This initiative aims to track all devices and patients, ensuring only certified products are used. The registry will help curb overuse and fix accountability. It will also aid in identifying patients during recalls and tracking real-world safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hDYFcAn
via IFTTT

Read More

Chemists’ strike: CDSCO moves to prevent shortages

The CDSCO has advised state drug controllers to prevent drug scarcity during the AIOCD's proposed e-pharmacy strike on May 20. Measures include ensuring pharmacies remain open, coordinating with police, and negotiating to keep some shops operational to avoid medicine deserts. The government emphasizes uninterrupted public access to medicines as a top priority.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uMGf1Jj
via IFTTT

Read More